Pharmaceuticals, Biotechnology and Life Sciences
Novartis announced on September 18 that Swissmedic has approved Entresto (sacubitril/valsartan), previously known as LCZ696, to reduce the risk of cardiovascular…
FDA announced on September 15 that Butala Emporium, Inc of Jackson Heights, NY, is voluntarily recalling eleven Ayurvedic (dietary) supplements because the products…
Allergan plc and Gedeon Richter Plc. have announced that the U.S. Food and Drug Administration (FDA) has approved Vraylartm (cariprazine) capsules,…
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly reported that the Company’s Jardiance (empagliflozin) had reduced the risk of the…
Allergan and U.S. Women’s Health Alliance (USWHA), an organization focused on promoting high-quality, affordable healthcare for women, have announced an…
Horizon Discovery Group plc Enters Bioproduction Cell Line Licensing Agreement with LakePharma, Inc. Horizon Discovery Group plc, the international life…
Johnson & Johnson has Announced BARDA Funding Award to Accelerate Ebola Vaccine Program Prime-boost vaccine regimen in development at the…
Takeda Pharmaceutical Company Limited will participate in WIPO Re:Search, a consortium to accelerate research and development (R&D) of new drugs, vaccines,…
The European Commission has approved the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) for the treatment of adult patients with…
Alexion Pharmaceuticals, Inc. announced on September 1, 2015, that the European Commission has approved Strensiq (asfotase alfa) for long-term enzyme replacement…